# An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

> clinical trial · VERIFIED · 2026-07-09

Status: RECRUITING · Sponsor: AstraZeneca · Condition: Endometrial Cancer

- Company: AstraZeneca
- Sector: Endometrial Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07041606

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.